Effects of the permeability characteristics of different polymethacrylates on the pharmaceutical characteristics of verapamil hyhdrochloride-loaded microspheres

Journal of Microencapsulation

Volumn 21, Issue 2, 2004, Pages 175-189

  Kilicarslan M ^a   Baykara, Tamer ^a  

^a ANKARA UNIVERSITY   (Turkey)

Author keywords

Flow through cell; Microsphere; Polymethacrylates; Solvent evaporation method; Verapamil HC1

Indexed keywords

ACETONE; EUDRAGIT; EUDRAGIT RS; LIQUID PARAFFIN; METHANOL; MICROSPHERE; POLYMER; POLYMETHACRYLIC ACID DERIVATIVE; POLYSORBATE; SOLVENT; STEARIC ACID DERIVATIVE; SUCROSE; VERAPAMIL;

ARTICLE; CONTROLLED STUDY; DISSOLUTION; DRUG FORMULATION; DRUG RELEASE; EVAPORATION; FLOW KINETICS; MEDICAL INSTRUMENTATION; METHODOLOGY; MICROMORPHOLOGY; PARTICLE SIZE; PERMEABILITY; SCANNING ELECTRON MICROSCOPY; STATISTICAL ANALYSIS; SURFACE PROPERTY; VISCOSITY;

ACRYLIC RESINS; DRUG COMPOUNDING; MICROSCOPY, ELECTRON, SCANNING; MICROSPHERES; PARTICLE SIZE; PERMEABILITY; POLYMETHACRYLIC ACIDS; SOLVENTS; SURFACE PROPERTIES; VERAPAMIL;

EID: 12144290712     PISSN: 02652048     EISSN: None     Source Type: Journal    
DOI: 10.1080/02652040310001637820     Document Type: Article

References (41)

1. Ammar, H. O. and Khalil, R. M., 1997, Preparation and evaluation of sustained release solid dispersions of drugs with Eudragit polymers. Drug Development and Industrial Pharmacy, 23, 1043-1054.
2. Barkai, A., Pathak, Y. V. and Benita, S., 1990, Polyacrylate (Eudragit retard) microspheres for oral controlled release of nifedipine. I. Formulation design and process optimisation. Drug Development and Industrial Pharmacy, 16, 2057-2075.
3. Benoit, J. P. and Marchais, H., 1996, Biodegredable microspheres: Advances in production technology. In Microencapsulation, Methods and Industrial Applications, edited by S. Benita (New York: Marcel Dekker).
4. Bogataj, M., Mrhar, A., Grabnar, I., Rajtman, Z., Bukovec, P., Srcic, S. and Urleb, U., 2000, The influence of magnesium stearate on the characteristics of mucoadhesive microspheres. Journal of Microencapsulation, 17, 499-508.
5. Brogden, R. N. and Benfield, P., 1996, Verapamil, a review of its pharmacological properties and therapeutic use in coronary artery disease. Drugs, 51, 792-819.
6. Catalog of Röhm Pharma GmbH, Eudragit Data Sheets, Industrial Products Division, Weiterstadt.
7. Das, S. K. and Das, N. G., 1998, Preparation and in vitro dissolution profile of dual polymer, (Eudragit RS 100 and RL 100) microparticles of diltiazem hydrochloride. Journal of Microencapsulation, 15, 445-452.
8. Dashevsky, A. and Zessin, G., 1997, The effect of ethylcellulose molecular weight on the properties of theophylline microspheres. Journal of Microencapsulation, 14, 273-280.
9. Follonier, N. and Doelker, E., 1992, Biopharmaceutical comparison of oral multiple-unit and single-unit sustained-release dosage forms. S.T.P. Pharma Sciences, 2, 141-158.
10. Gibaldi, M. and Feldman, S., 1967, Establishment of sink conditions in dissolution rate determinations. Theoretical considerations and application to non-disintegrating dosage forms. Journal of Pharmaceutical Sciences, 56, 1238-1242.
11. Giunchedi, P., Conte, U., Maggi, L. and La Manna, A., 1992, Hydropilic matrices for the extended release of a model drug exhibiting pH-dependent solubility. International Journal of Pharmaceutics, 85, 141-147.
12. Goracinova, K., Klisarova, L. and Simov, A., 1995, Physical characterization and dissolution properties of verapamil HCl coprecipitates. Drug Development and Industrial Pharmacy, 21, 383-391.
13. Goto, S., Kawata, M., Nakamura, M., Maekawa, K. and Aoyama, T., 1986a, Eudragit RS and RL (acrylic resins) microcapsules as pH insensitive and sustained release preparations of ketoprofen. Journal of Microencapsulation, 3, 293-304.
14. Goto, S., Kawata, M., Nakamura, M., Maekawa, K. and Aoyama, T., 1986b, Eudragit E, L and S (acrylic resins) microcapsules as pH sensitive release preparations of ketoprofen. Journal of Microencapsulation, 3, 305-316.
15. Goto, S., Kawata, M., Nakamura, M., Nagatsuma, Y., Fujinaga, K. and Aoyama, T., 1988, Evaluation of the sustained release properties of Eudragit RS, RL and S (acrylic resins) microcapsules containing ketoprofen in beagle dogs. Journal of Microencapsulation, 5, 343-360.
16. Hamann, S. R., Bloumin, R. A. and McAllister, Jr, R. G., 1984, Clinical pharmacokinetics of Verapamil. Clinical Pharmacokinetics, 9, 26-41.
17. Higuchi, T., 1963, Mechanism of sustained-action medication: theoretical analysis of rate of release of solid drug dispersed in solid matrices. Journal of Pharmaceutical Sciences, 52, 1145-1149.
18. Huang, H.P. and Ghebre-Sellasie, I., 1989, Preparation of microspheres of water-soluble pharmaceuticals. Journal of Microencapsulation, 6, 219-225.
19. Karim, A. and Piergies, A., 1995, Verapamil stereoisomerism: Enantiomeric ratios in plasma depedent on peak concentrations, oral input rate, or both. Clinical Pharmacology and Therapeutics, 58, 174-184.
20. Kawata, M., Nakamura, M., Goto, S. and Aoyama, T., 1986, Preparation and dissolution pattern of Eudragit RS microcapsules containing ketoprofen. Chemical Pharmaceutical Bulletine, 34, 2618-2623.
21. Kibbe, A.H., 2000, Handbook of Pharmaceutical Excipients (Washington, DC: American Pharmaceutical Association and Pharmaceutical Press).
22. Kiliçarslan, M. and Baykara, T., 2003, The effect of the drug/polymer ratio on the properties of the verapamil HCl loaded microspheres. International Journal of Pharmaceutics, 252, 99-109.
23. Kim, C.K., Kim, M.J., Oh, K.H., 1994, Preparation and evaluation of sustained release microspheres of terbutaline sulfate. International Journal of Pharmaceutics, 106, 213-219.
24. Kislalioglu, M.S., Khan, M.A., Blount, C., Goettsch, R.W. and Bolton, S., 1991, Physical characterization and dissolution properties of Ibuprofen: Eudragit coprecipitates. Journal of Pharmaceutical Sciences, 80, 799-804.
25. Langenbucher, F., 1972, Linearization of dissolution rate curves by the Weibull distribution. Journal of Pharmaceutics and Pharmacology, 24, 979-981.
26. Lehmann, K.O.R., 1997, Chemistry and application properties of polymethacrylate coating systems. In Aqueous Polymeric Coating for Pharmaceutical Dosage Forms, edited by J.W. McGinity (New York: Marcel Dekker).
27. McTavish, D. and Sorkin, E.M., 1989, Verapamil, an updated review of its pharmacokinetic properties, and therapeutic use in hypertension. Drugs, 38, 19-76.
28. Perumal, D., 2001, Microencapsultion of ibuprofen and Eudragit RS 100 by the emulsion solvent diffusion technique. International Journal of Pharmaceutics, 218, 1-11.
29. Pongpaibul, B.Y., Price, J.C. and Whitworth, 1984, Preparation and evaluation of controlled release indomethacin microspheres. Drug Development and Industrial Pharmacy, 10, 1597-1616.
30. Pongpaibul, Y. and Whitworth, C.W., 1986, Preparation and in vitro dissolution characteristics of propranolol microcapsules. International Journal of Pharmaceutics, 33, 243-248.
31. Rawle, A.F., 1993, The importance of particle size analyses in the pharmaceutical industry. Malvern Instruments Application Note Number MRK 125-02.
32. Soppimath, K.S., Kulkarni, A.R. and Aminabhavi, T.M., 2001, Encapsulation of antihypertensive drugs in cellulose-based matrix microspheres: Characterization and release kinetics of microspheres and tableted microspheres. Journal of Microencapsulation, 18, 397-409.
33. US Phamacopoeia 24, 2000 (Rockville: US Pharmacopeial Convention).
34. Vachon, M.G. and Nairn, J.G., 1995, Physico-chemical evaluation of acetylsalicylic acid-Eudragit RS 100 microspheres prepared using a solvent-partition method. Journal of Microencapsulation, 12, 287-305.
35. Watts, P.J., Davies, M.C. and Melia, C.D., 1991, Encapsulation of 5-aminosalicylic acid into Eudragit RS microspheres and modulation of their release characteristics by use of surfactants. Journal of Controlled Release, 16, 311-318.
36. Wingard, B.L., Brody, T.M., Larner, J. and Schwartz, A., 1991, Human Pharmacology Molecular to Clinical: Calcium Antagonists (London: Wolfe).
37. Yüksel, N. and Baykara, T., 1996a, Interaction between nicardipine hydrochloride and polymeric microspheres for a controlled release system. International Journal of Pharmaceutics, 140, 145-154.
38. Yüksel, N. and Baykara, T., 1996b, Preparation and evaluation of controlled release microspheres containing nicardipine hydrochloride. International Journal of Pharmaceutical Advances, 1, 398-407.
39. Yüksel, N. and Baykara, T., 1997, Preparation of polymeric microspheres by the solvent evaporation method using sucrose stearate as a droplet stabilizer. Journal of Microencapsulation, 14, 725-733.
40. Yüksel, N., Dinc, E., Onur, F. and Baykara, T., 1998, Influence of swelling degree on release of nicardipine hydrochloride from acrylic microspheres prepared by solvent evaporation method. Pharmaceutical Development and Technology, 3, 115-121.
41. Yüksel, N., Türkoǧlu, M. and Baykara, T., 2000, Modelling of the solvent evaporation method for the preparation of controlled release acrylic microspheres using neural networks. Journal of Microencapsulation, 17, 541-551.